SCHEMBL2014240

SCHEMBL2014240

CCCCCCCCCCCC(=O)OC(O)(O)CC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.53
LMNA P02545 2/20 0.50
PAM P19021 2/20 0.48
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
CES2 O00748 3/20 0.46
CES1 P23141 3/20 0.46
TSHR P16473 5/20 0.46
PPARG P37231 6/20 0.45
PPARD Q03181 6/20 0.45
PPARA Q07869 6/20 0.45
HDAC11 Q96DB2 5/20 0.45
GPR84 Q9NQS5 4/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
PTPN1 P18031 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549027 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL7054538 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL7048641 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL7052204 0.98 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL28942700 0.90 FAAH (0.54) LMNAMAPTCES1PPARGPPARD
SCHEMBL9954028 0.86 LMNA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL11619204 0.86 LMNA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL27695234 0.83 DGKA (0.57) DGKALMNAPAMMAPTMAPK1
SCHEMBL25682071 0.83 DGKA (0.57) DGKALMNAPAMMAPTMAPK1
SCHEMBL7047742 0.83 ALDH1A1 (0.50) DGKALMNACES2CES1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117460524-A Transdermal insulin formulations and methods of use thereof 透皮给药解决方案公司(DBA无针注射器医药) 2024-01-26 CN claimed
US-20230149309-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-05-18 US claimed
EP-4117633-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-01-18 EP claimed
WO-2021191462-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2021-09-30 WO claimed
EP-4681738-A1 1,4-POLYISOPRENE DISPERSION SYSTEM, PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF Suzhou Haiyi Biomedical Technology Co., Ltd (CN) 2026-01-21 EP disclosed
CN-119112780-A 1, 4-Polyisoprene dispersion system, pharmaceutical active ingredient and application thereof 苏州海益生物医药科技有限公司 2024-12-13 CN disclosed
CN-117460524-A Transdermal insulin formulations and methods of use thereof 透皮给药解决方案公司(DBA无针注射器医药) 2024-01-26 CN disclosed
CN-117119897-A Use of gossypol and methane inhibitors for reducing the formation of methane resulting from digestive activities of ruminants 帝斯曼知识产权资产管理有限公司 2023-11-24 CN disclosed
CN-116271061-A 1, 4-polyisoprene dispersion system, pharmaceutical active ingredient and application thereof 苏州海益生物医药科技有限公司 2023-06-23 CN disclosed
US-20230149309-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-05-18 US disclosed
US-20230149309-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-05-18 US disclosed
EP-4117633-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-01-18 EP disclosed
CN-113840635-A Oral compositions and methods of use 3M创新有限公司 2021-12-24 CN disclosed
CN-113811282-A Oral compositions and methods of use 3M创新有限公司 2021-12-17 CN disclosed
WO-2021191462-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2021-09-30 WO disclosed
WO-2021191462-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2021-09-30 WO disclosed
CN-109152936-B Therapeutic toothpaste and related methods and kits 3M创新有限公司 2021-08-27 CN disclosed
CN-112867462-A Dental appliance with structured surface 3M创新有限公司 2021-05-28 CN disclosed
EP-2512420-A2 USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR TREATING SEBORRHEA Pierre Fabre Dermo-Cosmétique (FR) 2012-10-24 EP disclosed
WO-2011073370-A2 USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR TREATING SEBORRHEA PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-06-23 WO disclosed